News Type: Publications

  • May 28, 2021

Industry News: Ori Biotech and Vineti have formed strategic partnership to deliver integrated manufacturing and supply chain solutions for cell and gene therapies

Publication: Select Science

Ori Biotech, an innovator in cell and gene therapy manufacturing, and Vineti, a provider of leading digital enterprise platforms for cell and gene therapy supply…

  • May 26, 2021

Ori Biotech and Vineti collaborate on digital platform for CGTs

Publication: Manufacturing Chemist

Ori Biotech and Vineti are partnering to produce an integrated solution to streamline the manufacture and delivery of cell and gene therapies (CGTs).

Ori provides…

  • April 20, 2021

McKesson Ventures highlights investment priorities amidst a trail of successful exits

Publication: MedCity News

McKesson Ventures is one of the most active investors in the biopharma software sector with Vineti, Komodo Health, Evidation and M2Gen among its portfolio companies.…

  • April 1, 2021

Six Cell and Gene Therapy Commercialization Trends

Publication

Amy DuRoss, CEO and Co-founder, Vineti and Keith Martino, VP/General Manager, Biopharma Services, Cardinal Health Specialty Solutions discuss what to watch in the next 12…

  • March 24, 2021

Biopharmaceutical and technology leaders form collaboration to promote standards and a modern patient ID for advanced therapies

Publication: Globe Newswire

SAN FRANCISCO, March 24, 2021 (GLOBE NEWSWIRE) -- A broad coalition of biopharmaceutical and technology leaders today announced a new strategic collaboration to promote new…

  • March 24, 2021

Exclusive: An industry consortium wants to standardize cell tracking for regenerative meds. Could that avert a disaster?

Publication: Endpoints News

In the fast-moving world of regenerative medicine, the open secret among industry experts is that manufacturing is exceedingly difficult and will take a Herculean effort…

  • February 17, 2021

How to Evolve and Mature Tech for Biotech and Pharma

Publication: PM360

In the third part of our three series podcast with Vineti, Chief Technology Officer Phil Calvin speaks about the technology that most excites him and…

  • January 13, 2021

Lessons Learned: What to Know About Producing Personalized Therapies

Publication: PM360

In the second of our three-series podcast with Vineti, Chief Commercial Officer Joe DePinto provides a first-hand look at what it takes to actually produce…

  • January 11, 2021

Introducing new Vineti PTM® flexibility features: next-gen label printing and rescheduling innovations deliver critical workflow options that advanced therapies require

Publication: Globe Newswire

SAN FRANCISCO, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Vineti, developer of the leading digital platform of record for personalized therapeutics, today announced a new suite…

  • December 15, 2020

Industrializing Personalized Therapeutics: Can You Really “Mass Customize” Patient-specific Pharmaceuticals?

Publication: PM360

In the first of a three-series podcast with Vineti, CEO and Founder Amy DuRoss discusses the rapid growth of cell and gene therapies and whether…